Literature DB >> 22379172

State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management.

D Jenkins1, E Mayer, N Screaton, M Madani.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease caused by chronic obstruction of pulmonary artery branches following episodes of pulmonary embolism and incomplete thrombus resolution. The prognosis of patients with CTEPH is poor unless an early diagnosis is made and treatment is initiated. Chest radiography and echocardiography are used in the initial assessment of suspected pulmonary hypertension. A diagnosis of CTEPH may be confirmed by the presence of a mismatched wedge-shaped perfusion deficit during ventilation/perfusion scintigraphy or characteristic findings during multi-slice computed tomography (CT) angiography, including a mosaic perfusion pattern, dilatation of proximal pulmonary arteries and right heart chambers, and the presence of vascular stenosis or obstruction. Prior to possible surgery, pulmonary angiography remains the definitive diagnostic technique, indicating the site and accessibility of the obstruction. However, many centres utilise CT and magnetic resonance imaging following recent advances in these noninvasive techniques. Haemodynamic evaluation via right heart catheterisation is also mandatory, as pulmonary vascular resistance is the most important determinant of both prognosis and the risk associated with pulmonary endarterectomy surgery. Accurate CTEPH diagnosis and characterisation of its extent and distribution are imperative to allow the prompt initiation of treatment, particularly surgical pulmonary endarterectomy in eligible patients.

Entities:  

Mesh:

Year:  2012        PMID: 22379172     DOI: 10.1183/09059180.00009211

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  24 in total

1.  The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?

Authors:  Rajive Tandon; Robert P Baughman; Janice Stanley; Ali A Khan
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

3.  Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

Authors:  F N Rahaghi; J C Ross; M Agarwal; G González; C E Come; A A Diaz; G Vegas-Sánchez-Ferrero; A Hunsaker; R San José Estépar; A B Waxman; G R Washko
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

4.  Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance.

Authors:  Jan B Hinrichs; Julius Renne; Marius M Hoeper; Karen M Olsson; Frank K Wacker; Bernhard C Meyer
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

5.  [Pulmonary hypertension : What is new in therapy?].

Authors:  N Sommer; M Hecker; K Tello; M Richter; C Liebetrau; M A Weigand; W Seeger; A Ghofrani; H Gall
Journal:  Anaesthesist       Date:  2016-08       Impact factor: 1.041

Review 6.  Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies.

Authors:  Alan B Goldberg; Wojciech Mazur; Dinesh K Kalra
Journal:  Cardiovasc Diagn Ther       Date:  2017-08

7.  Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients.

Authors:  Christian Schoenfeld; Jan B Hinrichs; Karen M Olsson; Martin-Alexander Kuettner; Julius Renne; Till Kaireit; Christoph Czerner; Frank Wacker; Marius M Hoeper; Bernhard C Meyer; Jens Vogel-Claussen
Journal:  Eur Radiol       Date:  2018-10-11       Impact factor: 5.315

Review 8.  Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.

Authors:  Fatima A Ballout; Ahmad S Manshad; Tochukwu M Okwuosa
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

9.  Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: How can patients be better selected?

Authors:  Juan C Grignola; Enric Domingo
Journal:  World J Cardiol       Date:  2013-03-26

10.  Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Akihiro Hirashiki; Shiro Adachi; Yoshihisa Nakano; Yoshihiro Kamimura; Shigetake Shimokata; Kyosuke Takeshita; Toyoaki Murohara; Takahisa Kondo
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.